Fidelma Dunne
University College Hospital
Publications 213
#1Catherine L. Finnegan (Rotunda Hospital)
#2Fionnuala Breathnach (Rotunda Hospital)H-Index: 8
Last.Vinete Ciprike (Our Lady of Lourdes Hospital)
view all 12 authors...
Abstract Background Preeclampsia, preterm birth and low birth weight represent key contributing factors to perinatal morbidity and mortality. Pregnancies complicated by type 1 and type 2 diabetes are at increased risk of these complications, which are purported to be largely attributed to placental dysfunction. Studies investigating a potential role for aspirin therapy in optimizing perinatal outcome have consistently failed to demonstrate a benefit among women with pre-existing diabetes, and ye...
#1Delia Bogdanet (National University of Ireland, Galway)H-Index: 1
#2Aoife M. Egan (National University of Ireland, Galway)H-Index: 11
Last.Fidelma Dunne (National University of Ireland, Galway)H-Index: 35
view all 9 authors...
Background Gestational diabetes (GDM) is associated with an increased lifetime risk for the development of glucose abnormalities, metabolic syndrome, cardiovascular disease, depression and tumours. Despite this high risk of additional comorbidities, there is no standardised approach to the long-term follow-up of women with a previous diagnosis of GDM. Also, there is no standardisation of outcome selection and reporting in studies involving this population. This increases the risk of reporting bi...
1 CitationsSource
#1Delia Bogdanet (NUI: National University of Ireland)H-Index: 1
#2Catriona Reddin (NUI: National University of Ireland)
Last.Fidelma Dunne (NUI: National University of Ireland)H-Index: 35
view all 23 authors...
Aims/hypothesis Gestational diabetes mellitus (GDM) is linked with a higher lifetime risk for the development of impaired fasting glucose, impaired glucose tolerance, type 2 diabetes, the metabolic syndrome, cardiovascular disease, postpartum depression and tumours. Despite this, there is no consistency in the long-term follow-up of women with a previous diagnosis of GDM. Further, the outcomes selected and reported in the research involving this population are heterogeneous and lack standardisat...
#1Aoife M. Egan (Mayo Clinic)H-Index: 11
#2Fidelma Dunne (National University of Ireland, Galway)H-Index: 35
#1Jürgen Harreiter (Medical University of Vienna)H-Index: 12
#2David Simmons (USYD: University of Sydney)H-Index: 44
Last.Alexandra Kautzky-Willer (Medical University of Vienna)H-Index: 39
view all 28 authors...
OBJECTIVE In our randomized controlled trial, we investigated the impact of healthy eating (HE) aiming for restricted gestational weight gain (GWG) and physical activity (PA) interventions on maternal and neonatal lipid metabolism. RESEARCH DESIGN AND METHODS Obese pregnant women ( n = 436) were included before 20 weeks gestation and underwent glucose testing (oral glucose tolerance test) and lipid profiling at baseline and 24–28 and 35–37 gestational weeks after an at least 10-h overnight fast....
2 CitationsSource
#1Alice E Hughes (University of Exeter)H-Index: 1
#2M. Geoffrey Hayes (NU: Northwestern University)H-Index: 30
Last.Rachel M. Freathy (University of Exeter)H-Index: 36
view all 10 authors...
Using genetic scores for fasting plasma glucose (FPG GS) and Type 2 diabetes (T2D GS), we investigated whether different diagnostic criteria for gestational diabetes (GDM) have different implications for genetic susceptibility to later T2D in women from the the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) and Atlantic Diabetes in Pregnancy (DIP) studies. To investigate different features of WHO (1999) and IADPSG (2010) criteria for diagnosing GDM, cases were divided into three subgroups: (...
#1Jose A. HalperinH-Index: 31
#2Dongdong MaH-Index: 1
Last.Fidelma DunneH-Index: 35
view all 6 authors...
pGCD59 is an emerging biomarker for diabetes and GDM. In 1,000 women undergoing 2-step GDM screening, pGCD59 at weeks 24-28 classified GDM subjects with high sensitivity and specificity and was associated with the risk of large for gestational age (LGA) babies. GDM early in pregnancy is a public health challenge because it increases the risk of adverse outcomes. To assess pGCD59 as a predictor of early GDM and abnormal outcomes, levels of pGCD59 were measured in 807 samples from women undergoing...
#1Mireille N. M. van Poppel (PHRI: Public Health Research Institute)H-Index: 39
#2David Simmons (USYD: University of Sydney)H-Index: 44
Last.Gernot Desoye (Medical University of Graz)H-Index: 47
view all 25 authors...
Aims/hypothesis Offspring of obese women are at increased risk of features of the metabolic syndrome, including obesity and diabetes. Lifestyle intervention in pregnancy might reduce adverse effects of maternal obesity on neonatal adiposity.
1 CitationsSource
#1Rosa Corcoy (Autonomous University of Barcelona)H-Index: 19
#2Lilian C Mendoza (Autonomous University of Barcelona)H-Index: 2
Last.Mireille N. M. van Poppel (University of Graz)H-Index: 39
view all 30 authors...
Background & aims: As vitamin D deficiency is associated with an increased risk of gestational diabetes mellitus (GDM), we aimed to test vitamin D supplementation as a strategy to reduce GDM risk (evaluated after fasting plasma glucose (FPG), insulin resistance and weight gain) in pregnant overweight/obese women. Methods: The DALI vitamin D multicenter study enrolled women with prepregnancy body mass index (BMI) ≥ 29 kg/m 2 , ≤19 + 6 weeks of gestation and without GDM. Participants were randomiz...
#1Aoife M. Egan (University Hospital Galway)H-Index: 11
#2M. J. Brassill (South Tipperary General Hospital)
Last.Fidelma Dunne (University Hospital Galway)H-Index: 35
view all 34 authors...